(Q33398502)

26 July 2017

1 reference

title

Photodynamic therapy for prostate cancer--a review of current status and future promise (English)

1 reference

26 July 2017

1 reference

3

Mark Emberton

1 reference

26 July 2017

Caroline M Moore

1

1 reference

26 July 2017

Doug Pendse

series ordinal

2

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

26 July 2017

published in

Nature Reviews Urology

1 reference

26 July 2017

volume

6

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

18-30

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpuro1274

26 July 2017

exact match

0 references

cites work

Development of a novel targeting system for lethal photosensitization of antibiotic-resistant strains of Staphylococcus aureus

1 reference

12 December 2020

Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project

1 reference

12 December 2020

Assessment of Cutaneous Photosensitivity of TOOKAD (WST09) in Preclinical Animal Models and in Patients¶

1 reference

12 December 2020

Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy.

1 reference

12 December 2020

Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin

1 reference

12 December 2020

Targeted photodynamic therapy via receptor mediated delivery systems

1 reference

12 December 2020

An interstitial light assembly for photodynamic therapy in prostatic carcinoma

1 reference

12 December 2020

The current use and future trends of focal surgical therapy in the management of localized prostate cancer

1 reference

12 December 2020

Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer

1 reference

12 December 2020

The male lumpectomy: rationale for a cancer targeted approach for prostate cryoablation. A review

1 reference

12 December 2020

Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy

1 reference

12 December 2020

Photodynamic therapy and anti-tumour immunity.

1 reference

12 December 2020

Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements

1 reference

12 December 2020

Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy.

1 reference

12 December 2020

Acne vulgaris: lasers, light sources and photodynamic therapy--an update 2007.

1 reference

12 December 2020

Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy

1 reference

12 December 2020

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival

1 reference

12 December 2020

Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI

1 reference

12 December 2020

Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light.

1 reference

12 December 2020

Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide

1 reference

12 December 2020

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities

1 reference

12 December 2020

In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy.

1 reference

12 December 2020

Fractionated photodynamic therapy for a human oral squamous cell carcinoma xenograft

1 reference

12 December 2020

Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study

1 reference

12 December 2020

Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes

1 reference

12 December 2020

Active surveillance with selective delayed intervention is the way to manage 'good-risk' prostate cancer

1 reference

12 December 2020

Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy.

1 reference

12 December 2020

Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid

1 reference

12 December 2020

Photodynamic therapy in the canine prostate using motexafin lutetium

1 reference

12 December 2020

Polymeric micelles to deliver photosensitizers for photodynamic therapy

1 reference

12 December 2020

Vascular Targeted Photodynamic Therapy With Palladium-Bacteriopheophorbide Photosensitizer for Recurrent Prostate Cancer Following Definitive Radiation Therapy: Assessment of Safety and Treatment Response

1 reference

12 December 2020

In vivo laser light distribution in human prostatic carcinoma

1 reference

12 December 2020

Photodynamic therapy for neovascular age-related macular degeneration

1 reference

12 December 2020

Active surveillance for prostate cancer: trials and tribulations

1 reference

12 December 2020

Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer

1 reference

12 December 2020

Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors

1 reference

12 December 2020

Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate.

1 reference

12 December 2020

Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer

1 reference

12 December 2020

Antibody-directed photodynamic therapy of methicillin resistant Staphylococcus aureus.

1 reference

12 December 2020

Focal therapy for prostate cancer

1 reference

12 December 2020

Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy

1 reference

12 December 2020

Control of prostate cancer by transrectal HIFU in 227 patients.

1 reference

12 December 2020

Photodynamic therapy of localised prostatic cancer

1 reference

12 December 2020

Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy

1 reference

12 December 2020

Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy

1 reference

12 December 2020

Photodynamic therapy targeted to pathogens

1 reference

12 December 2020

PDT-associated host response and its role in the therapy outcome

1 reference

12 December 2020

Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland

1 reference

12 December 2020

In situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland

1 reference

12 December 2020

Photodynamic therapy for urological malignancies: past to current approaches

1 reference

12 December 2020

Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses

1 reference

12 December 2020

Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX.

1 reference

12 December 2020

Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro

1 reference

12 December 2020

Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen

1 reference

12 December 2020

WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model.

1 reference

12 December 2020

Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.

1 reference

12 December 2020

Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer

1 reference

12 December 2020

Scavenger-receptor targeted photodynamic therapy

1 reference

12 December 2020

Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates

1 reference

12 December 2020

PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy

1 reference

12 December 2020

Photodynamic therapy for cancer of the pancreas.

1 reference

12 December 2020

Prompt assessment of WST11-VTP outcome using luciferase transfected tumors enables second treatment and increase in overall therapeutic rate.

1 reference

12 December 2020

Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland

1 reference

12 December 2020

Efficient synthesis and photodynamic activity of porphyrin-saccharide conjugates: targeting and incapacitating cancer cells.

1 reference

12 December 2020

Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer

1 reference

12 December 2020

Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NCPURO1274

1 reference

Dimensions Publication ID

26 July 2017

1020857869

0 references

1 reference